Takamatsu J - Search Results

1

Inhibitor development, safety, and efficacy of Advate^® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan.

Taki M, Fukutake K, Matsushita T, Nogami K, Shima M, Yoshioka A, Takamatsu J, Arai M, Takagi H, Uchikawa H, Engl W, Shirahata A. Taki M, et al. Among authors: takamatsu j. Int J Hematol. 2019 Jan;109(1):70-78. doi: 10.1007/s12185-018-2499-y. Epub 2018 Jul 24. Int J Hematol. 2019. PMID: 30043332

2

Perioperative safety and hemostatic efficacy of Advate^® in patients with hemophilia A in a postmarketing surveillance in Japan.

Nogami K, Takedani H, Shima M, Yoshioka A, Matsushita T, Takamatsu J, Taki M, Fukutake K, Uchikawa H, Takagi H, Arai M, Engl W, Shirahata A. Nogami K, et al. Among authors: takamatsu j. Int J Hematol. 2018 Jul;108(1):22-29. doi: 10.1007/s12185-018-2434-2. Epub 2018 Mar 28. Int J Hematol. 2018. PMID: 29594923 Clinical Trial.

3

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan.

Taki M, Fukutake K, Matsushita T, Nogami K, Shima M, Yoshioka A, Takamatsu J, Arai M, Takagi H, Uchikawa H, Engl W, Shirahata A. Taki M, et al. Among authors: takamatsu j. Int J Hematol. 2019 Feb;109(2):241. doi: 10.1007/s12185-018-02564-z. Int J Hematol. 2019. PMID: 30560315

4

Inhibitor development, safety and efficacy of Advate^® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan.

Fukutake K, Taki M, Matsushita T, Nogami K, Shima M, Yoshioka A, Takamatsu J, Uchikawa H, Takagi H, Arai M, Engl W, Shirahata A. Fukutake K, et al. Among authors: takamatsu j. Int J Hematol. 2019 Mar;109(3):336-345. doi: 10.1007/s12185-018-02574-x. Epub 2019 Jan 2. Int J Hematol. 2019. PMID: 30604312 Clinical Trial.

5

Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).

Nogami K, Taki M, Matsushita T, Kojima T, Oka T, Ohga S, Kawakami K, Sakai M, Suzuki T, Higasa S, Horikoshi Y, Shinozawa K, Tamura S, Yada K, Imaizumi M, Ohtsuka Y, Iwasaki F, Kobayashi M, Takamatsu J, Takedani H, Nakadate H, Matsuo Y, Matsumoto T, Fujii T, Fukutake K, Shirahata A, Yoshioka A, Shima M; J-HIS2 study group. Nogami K, et al. Among authors: takamatsu j. Haemophilia. 2022 Sep;28(5):745-759. doi: 10.1111/hae.14602. Epub 2022 Jun 11. Haemophilia. 2022. PMID: 35689832

6

Recurrent intramural hematoma of the small intestine in a severe hemophilia A patient with a high titer of factor VIII inhibitor: a case report and review of the literature.

Katsumi A, Matsushita T, Hirashima K, Iwasaki T, Adachi T, Yamamoto K, Kojima T, Takamatsu J, Saito H, Naoe T. Katsumi A, et al. Among authors: takamatsu j. Int J Hematol. 2006 Aug;84(2):166-9. doi: 10.1532/IJH97.06053. Int J Hematol. 2006. PMID: 16926140

7

Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation.

Miyawaki Y, Suzuki A, Fujimori Y, Takagi A, Murate T, Suzuki N, Katsumi A, Naoe T, Yamamoto K, Matsushita T, Takamatsu J, Kojima T. Miyawaki Y, et al. Among authors: takamatsu j. Int J Hematol. 2010 Sep;92(2):405-8. doi: 10.1007/s12185-010-0659-9. Epub 2010 Aug 11. Int J Hematol. 2010. PMID: 20700669 No abstract available.

8

Identification of protein Salpha gene mutations including four novel mutations in eight unrelated patients with protein S deficiency.

Okada H, Takagi A, Murate T, Adachi T, Yamamoto K, Matsushita T, Takamatsu J, Sugita K, Sugimoto M, Yoshioka A, Yamazaki T, Saito H, Kojima T. Okada H, et al. Among authors: takamatsu j. Br J Haematol. 2004 Jul;126(2):219-25. doi: 10.1111/j.1365-2141.2004.05026.x. Br J Haematol. 2004. PMID: 15238143 Free article.

9

Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders.

Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Toyoda H, Kumada T, Yamamoto K, Matsushita T, Kojima T, Takamatsu J, Goto H. Honda T, et al. Among authors: takamatsu j. J Med Virol. 2013 Feb;85(2):228-34. doi: 10.1002/jmv.23444. Epub 2012 Nov 14. J Med Virol. 2013. PMID: 23160930

10

Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.

Yamamoto K, Takamatsu J, Saito H. Yamamoto K, et al. Among authors: takamatsu j. Int J Hematol. 2007 May;85(4):287-93. doi: 10.1532/IJH97.06222. Int J Hematol. 2007. PMID: 17483070 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters